[ad_1] The bad news for Rolls-Royce Holdings (LSE: RR.) shares is they’ve dropped 22% since February’s 52-week high. Falling more than 20%, that’s technically considered a crash. But the good news is that shareholders who bought at the end of…
[ad_1] CHA|EPS ¥0.49|Rev ¥2.97B|Net Income ¥33.9M Chagee Holdings Limited reported a challenging fourth quarter as the Chinese teahouse operator posted non-GAAP earnings of ¥0.49 per share on revenue of ¥2.97B, marking a 10.8% decline from the ¥3.33B recorded in the…
[ad_1] The bad news for Rolls-Royce Holdings (LSE: RR.) shares is they’ve dropped 22% since February’s 52-week high. Falling more than 20%, that’s technically considered a crash. But the good news is that shareholders who bought at the end of…
[ad_1] JSPR|EPS -$0.32|Net Loss $9.1M Jasper Therapeutics, Inc. reported a significantly narrower loss for the fourth quarter of 2025, reflecting improved cost management at the clinical-stage biotechnology company. The firm posted a loss of $0.32 per share for the quarter,…
[ad_1] At this time of year, it can be hard to avoid mention of the looming ISA deadline. That happens annually at the end of the tax year, which falls this weekend (5 April). It is for people to put…
[ad_1] TER Price $277.93 Change -5.9% Volume 919,041 Teradyne shares plunged 5.9% on Monday to $277.93 as semiconductor equipment stocks sold off across the board, with at least seven sector peers posting sharp declines in a broad-based retreat that weighed…
[ad_1] The London Stock Exchange is a mecca for passive income investors, with loads of quality shares offering generous dividends. And with most taking a tumble lately due to the Middle East conflict, dividend yields are higher now than a…
[ad_1] Amkor Technology shares tumbled 6.5% on Monday to close at $41.57, caught in a broad selloff that swept across the semiconductor equipment sector as six industry peers posted similar declines. The downdraft wasn’t company-specific. Amkor’s decline mirrored weakness across…
[ad_1] The deadline for the current Stocks and Shares ISA year is next Sunday (April 5). Given the increased attention on ISAs ahead of the deadline, some might be considering opening one for the first time. Even though it might…
[ad_1] Company Overview Satellos Bioscience Inc. (NASDAQ: MSLE) is a clinical-stage biotechnology company focused on developing SAT-3247 to treat degenerative muscle diseases like Duchenne muscular dystrophy. The company recently transitioned to the Nasdaq Global Market in February 2026. Key Financial…